Dachaigh › Degeneration Macular › Ohio
Sgrùdaidhean clionaigeach Degeneration Macular ann an Ohio
Tha 11 sgrùdaidhean airson Degeneration Macular a’ lorg phàirtichean aig làraichean ann an Ohio.
Bailtean ann an Ohio
Teacsa sgrùdaidh oifigeil (Beurla)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Cincinnati Eye Institute (Site 133), Cincinnati
A’ fastadhÌre 2/3
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Cincinnati Eye Institute, Cincinnati
- Cleveland Clinic Main Campus, Cleveland
A’ fastadhÌre 2/3
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Associates of Cleveland - Beachwood, Beachwood
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
A’ fastadhÌre 1/2
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Cincinnati Eye Institute, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Ohio State University, Columbus
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
- Cincinnati Eye Institute, Cincinnati
A’ fastadhÌre 1
Aoisean 6 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07734064Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
A’ fastadhÌre 2
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
- Cleveland Clinic, Cleveland
A’ fastadhSgrùdadh amharc
Aoisean 50 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07798323Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Associates of Cleveland, Beachwood
A’ fastadh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Cincinnati Eye Institute, Cincinnati
A’ fastadhSgrùdadh amharc
Aoisean 6 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07425574Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Cincinnati Eye Institute, Cincinnati
A’ fastadhÌre 3
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Cleveland Clinic | Cole Eye Institute, Cleveland
A’ fastadh
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 3 Dùbh 2024 · NCT05438732Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.